"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes

Prog Clin Biol Res. 1989:288:151-60.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Cytotoxicity, Immunologic
  • Humans
  • Immunization, Passive*
  • Interleukin-2 / pharmacology
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / transplantation*
  • Lymphocyte Activation / drug effects
  • Lymphocytosis / chemically induced
  • Mice
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / therapy

Substances

  • Interleukin-2